RGEN: Raised 2026 guidance after strong Q2 growth, margin gains, and BioLife acquisition announcementQuartr·22 hours agoBLFS+7.35%RGEN+10.90%
Are NG, BLFS, NRIM Obtaining Fair Deals for their Shareholders?PR Newswire·22 hours agoNG-2.35%BLFS+7.35%
Repligen Q2 GAAP EPS drops 65.38% to $0.09; revenue rises 12% to $204 millionPUBT·1 day ago, 06:14 AMRGEN+10.90%BLFS+7.35%
Cross-Sector Divergence: How Global Shifts Fracture US and International Equities in Mid-2026Global Report·1 day ago, 04:13 AMLSRCY-10.73%DHI+2.38%
Are UTZ, BLFS, FNWD Obtaining Fair Deals for their Shareholders?PR Newswire·Jul 23 at 11:10 AMFNWD+0.32%UTZ0.00%
Is Repligen (RGEN) Still Undervalued Following Its $1.5b BioLife Deal?Simplywall·Jul 23 at 08:19 AMRGEN+10.90%BLFS+7.35%
Biotech Stocks At 52-Week Highs - ADVB Surges +73%, BLFS Rises After Acquisition, FBRX, SLN, LBRXrttnews·Jul 23 at 03:38 AMSLN-4.31%FBRX+0.20%
BioLife Solutions to Be Acquired by Repligen for $11.25 Cash Plus 0.1442 Share Per ShareTradingView·Jul 22 at 04:23 PMBLFS+7.35%RGEN+10.90%
